La maladie de Parkinson en France (serveur d'exploration) - Exploration (Accueil)

Index « Auteurs » - entrée « J L Montastruc »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
J L Mege < J L Montastruc < J L Renard  Facettes :

List of bibliographic references indexed by J L Montastruc

Number of relevant bibliographic references: 24.
[0-20] [0 - 20][0 - 24][20-23][20-40]
Ident.Authors (with country if any)Title
003305 (2002) O. Rascol [France] ; J J Ferreira ; P. Payoux ; Ch Brefel-Courbon ; J L Montastruc[Management of levodopa-induced dyskinesia].
003570 (2001) O. Rascol [France] ; J. Ferreira ; J L Montastruc[Abnormal diurnal somnolence, "sleep attacks" and antiparkinson drugs].
003572 (2001) O. Rascol [France] ; N. Fabre ; C. Brefel-Courbon ; J L MontastrucThe pharmacologic treatment of gait ignition failure.
003864 (2000) O. Rascol [France] ; J L Montastruc[Role of dopaminergic agonists].
003C58 (1999) O. Rascol [France] ; C. Brefel-Courbon ; S. Descombes ; J L MontastrucClinical pharmacology of levodopa-induced dyskinesia in parkinsonian patients.
004475 (1996) J L Montastruc [France] ; O. Rascol ; J M SenardNew directions in the drug treatment of Parkinson's disease.
004484 (1996) J L Montastruc [France] ; J M Senard ; O. Rascol ; A. RascolAutonomic nervous system dysfunction and adrenoceptor regulation in Parkinson's disease. Clinical and pharmacological consequences.
004486 (1996) O. Rascol [France] ; A J Lees ; J M Senard ; Z. Pirtosek ; C. Brefel ; J L Montastruc ; D. FuellA placebo-controlled study of ropinirole, a new D2 agonist, in the treatment of motor fluctuations of L-DOPA-treated parkinsonian patients.
004692 (1995) J L Montastruc [France] ; O. Rascol ; J M Senard ; G. Houin ; A. RascolSublingual apomorphine: a new pharmacological approach in Parkinson's disease?
004699 (1995) J M Sénard [France] ; P. Verwaerde ; O. Rascol ; J L MontastrucEffects of acute levodopa administration on blood pressure and heart variability in never treated parkinsonians.
004912 (1994) M E Llau [France] ; L. Nguyen ; J M Senard ; O. Rascol ; J L Montastruc[Drug-induced parkinsonian syndromes: a 10-year experience at a regional center of pharmaco-vigilance].
004A02 (1994) O. Rascol [France] ; U. Sabatini [France] ; F. Chollet [France] ; N. Fabre [France] ; J M Senard [France] ; J L Montastruc [France] ; P. Celsis [France] ; J P Marc-Vergnes [France] ; A. Rascol [France]Normal activation of the supplementary motor area in patients with Parkinson's disease undergoing long-term treatment with levodopa.
004A44 (1994) J L Montastruc [France] ; O. Rascol [France] ; J M Senard [France] ; A. Rascol [France]A randomised controlled study comparing bromocriptine to which levodopa was later added, with levodopa alone in previously untreated patients with Parkinson's disease: a five year follow up.
004E51 (1991) J L Montastruc [France] ; O. Rascol ; J M Senard ; V. Gualano ; H. Bagheri ; G. Houin ; A. Lees ; A. RascolSublingual apomorphine in Parkinson's disease: a clinical and pharmacokinetic study.
004E55 (1991) G. Durrieu [France] ; J M Senard ; M A Tran ; A. Rascol ; J L MontastrucEffects of levodopa and bromocriptine on blood pressure and plasma catecholamines in parkinsonians.
004F52 (1991) A. Agniel [France] ; P. Celsis [France] ; G. Viallard [France] ; J L Montastruc [France] ; O. Rascol [France] ; J F Demonet [France] ; J P Marc-Vergnes [France] ; A. Rascol [France]Cognition and cerebral blood flow in lateralised parkinsonism: lack of functional lateral asymmetries.
005011 (1990) G. Durrieu [France] ; J M Senard ; O. Rascol ; M A Tran ; X. Lataste ; A. Rascol ; J L MontastrucBlood pressure and plasma catecholamines in never-treated parkinsonian patients: effect of a selective D1 agonist (CY 208-243).
005012 (1990) G. Durrieu [France] ; Y. Rispail ; E. Chatelut ; M. Berlan ; A. Rascol ; J L Montastruc ; P. MontastrucBeta-adrenergic sensitivity in Parkinson's disease: effect of levodopa treatment.
005156 (1989) M. Berlan [France] ; O. Rascol ; J. Belin ; J P Moatti ; A. Rascol ; J L MontastrucAlpha 2-adrenergic sensitivity in Parkinson's disease.
005219 (1989) J L Montastruc [France] ; O. Rascol [France] ; A. Rascol [France]A randomised controlled study of bromocriptine versus levodopa in previously untreated Parkinsonian patients: a 3 year follow-up.
005904 (????) J M Senard [France] ; J L Montastruc[Pharmacologic approach to autonomic failure].

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonFranceV1/Data/Main/Exploration
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Author.i -k "J L Montastruc" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Author.i  \
                -Sk "J L Montastruc" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    ParkinsonFranceV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    Author.i
   |clé=    J L Montastruc
}}

Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Wed May 17 19:46:39 2017. Site generation: Mon Mar 4 15:48:15 2024